Journal Information
Vol. 109. Issue 7.
Pages 651 (September 2018)
Vol. 109. Issue 7.
Pages 651 (September 2018)
Images in Dermatology
DOI: 10.1016/j.adengl.2018.05.029
Full text access
Rare Tongue Compromising of Mucocutaneous Leishmaniasis by Leishmania Subgenus Viannia
Raro compromiso lingual de leishmaniasis mucocutánea por Leishmania perteneciente al subgénero Viannia
Visits
...
R. Bueno-Filhoa, S. Vernala, C.M. Gomesb, A.M. Roselinoa,
Corresponding author
amfrosel@fmrp.usp.br

Corresponding author.
a Unidad de Dermatología, Departamento de Clínica Médica, Facultad de Medicina de Ribeirão Preto, Universidad de São Paulo, São Paulo, Brasil
b Unidad de Dermatología, Departamento de Clínica Médica, Universidad de Brasilia, Distrito Federal, Brasil
Article information
Full Text
Download PDF
Statistics
Figures (1)
Full Text

A 61-years-old male, native from Minas Gerais State, Southeastern Brazil (deny travels overseas), retired electrician, with dyslipidemia and hypertension was admitted for evaluation of an ulcer on his tongue, which appeared five months after an ulcer on the dorsum of his right foot. Histopathology of the previous foot ulcer described a chronic inflammatory process with granuloma formation. Spiramycin and fluconazole were prescribed without improvement, therefore it was surgically removed.

Clinical examination showed a 3.5 by 2.5cm well-circumscribed ulcerated lesion on the left side of his tongue (Figure 1 A), submandibular and lymphadenopathies on the left side. Histopathology on incisional tongue biopsy showed pseudoepiteliomatous hyperplasia and dermal lymphohistiocytic infiltrate, rich in plasma cells, with no microorganisms. Routine laboratory investigations and ELISA test for leishmaniasis were negative or normal, including negative results for human immunodeficiency virus. Leishmanin skin test was positive and polymerase chain reaction performed on tongue biopsies revealed Leishmania subgenus Viannia (corresponding to Leishmania Viannia braziliensis due to local Leishmania species epidemiology). He was treated with liposomal amphotericin B - 3000mg cumulative dose (35mg/kg administered for 28-days), and presented complete tongue healing two months after treatment (Figure 1B), without any adverse effect. Physicians working in American Tegumentary Leishmaniasis endemic areas should be aware of this rare mucous form presented here whose clinical aspect may be differentiated mainly from epidermoid carcinoma.

Figure 1
(0.17MB).

Please cite this article as: Bueno-Filho R, Vernal S, Gomes CM, Roselino AM. Raro compromiso lingual de leishmaniasis mucocutánea por Leishmania perteneciente al subgénero Viannia. Actas Dermosifiliogr. 2018;109:651.

Copyright © 2018. Elsevier España, S.L.U. and AEDV
Idiomas
Actas Dermo-Sifiliográficas (English Edition)

Subscribe to our newsletter

Article options
    NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
    NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
    NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
    NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
  • Additional material
Tools
NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
NOTICE Undefined index: tipo (includes_ws_v2/librerias/html/item.php[1273])
Supplemental materials
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.